Nevertheless, we cannot exclude that VPS4B downregulation may be beneficial for cells of advanced‐stage CRC, as RNAi‐mediated knockdown of VPS4B may promote resistance of multiple melanoma and breast cancer cells to chemotherapeutics (Lin et al, 2012; Tang et al, 2015). This evidence concerns the gene VPS4B and colorectal carcinoma.